Director of Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Andersen Eric, buys 23,629 shares worth $143,194
According to Merrimack Pharmaceuticals Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:05 PM, company Director, Andersen Eric disclosed buying 23,629 shares at a cost of $6.06. At the time of this transaction (Apr 12), this trade was worth $143,194 in total. As of Apr 12, Andersen Eric now owns 896,717 shares in total worth about $5,936,266.54.
For the last few recent trades made by Merrimack Pharmaceuticals Inc (NASDAQ:MACK) Director, Andersen Eric, we have the following information:
- SEC Form 4 filing: Nov 24: Bought 69,088 shares at the rate of $3.65 per share. Total worth of this trade was $252,171. Total number of shares owned as of Nov 24 were 873,088
- SEC Form 4 filing: Nov 12: Bought 56,490 shares at the rate of $3.65 per share. Total worth of this trade was $206,188. Total number of shares owned as of Nov 12 were 822,014
- SEC Form 4 filing: Aug 13: Bought 609 shares at the rate of $3.50 per share. Total worth of this trade was $2,132. Total number of shares owned as of Aug 13 were 820,055
Posted by
George Daniels
on Wednesday April 14 2021, 6:34 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
